Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
Vivian KoelbelAndré PfobBenedikt SchaefgenPeter SinnManuel FeisstMichael GolattaChristina GomezAnne StieberPaul BachGeraldine RauchJoerg HeilPublished in: Annals of surgical oncology (2021)
For patients without accompanying DCIS or multicentric disease, performing a distinct representative VAB (i.e., removing a well-placed clip marker) after NST suggests that VAB might reliably exclude residual cancer in the breast without surgery. This evidence will inform the design of future trials evaluating risk-adaptive surgery for exceptional responders to NST.
Keyphrases
- papillary thyroid
- minimally invasive
- end stage renal disease
- coronary artery bypass
- squamous cell
- ejection fraction
- chronic kidney disease
- prognostic factors
- lymph node
- surgical site infection
- peritoneal dialysis
- childhood cancer
- squamous cell carcinoma
- coronary artery disease
- patient reported outcomes
- combination therapy
- patient reported
- smoking cessation
- replacement therapy